Over the past couple of years, the top execs at Roche and Genentech have inked a flurry of deals aligning the global pair with several of the new players that have emerged in the booming AI and…
One of Wendy Lund’s earliest jobs was head of marketing at Planned Parenthood. As the youngest person on its management team, she introduced them to emerging new technologies, and in return, she…
Once largely a mystery to researchers, the far-flung realm of cells in the immune system has emerged as a fruitful sandbox for drug developers. A new UK biotech is leaning on research into the growing…
Every autumn, leaves fall from the trees and people start holiday shopping – and for the last few years Pfizer debuts a new ‘Know Pneumonia’ awareness TV ad. This year the commercial, launched a week…
AI biotech BenevolentAI is going public in the Netherlands, and it decided to go the SPAC route as part of one of the largest mergers in Europe to date. The AI biotech is joining with a SPAC known as…
Richard Lerner, the esteemed biochemist who pioneered a new way to develop monoclonal antibodies and led Scripps Research Institute to prominence, has passed away. A spokesperson for Scripps told the…
With the rush of AI permeating the biotech industry, another AI player is coming out well-organized and flush with cash. METiS Therapeutics announced this morning that it successfully put $86 million…
Are you ready to rumble? DTC brands that is. MarketingRx is launching a new monthly feature today called MarketingRx Matchup. We’re pitting two pharma brands’ DTC advertising in the same therapeutic…
Rare neurological disorders have long proved difficult for drug developers, with huge R&D budgets and commercial plans often going bust at the very last minute. Now, Acadia Pharma is touting a win for…
As Icelandic billionaire Róbert Wessman tries to take down AbbVie’s megablockbuster Humira in court, he’s also taking his biosimilar upstart to the big time with a $2.25 billion SPAC merger, Nasdaq…
